Anterior Olfactory Nucleus (AON) Neurons

Introduction

Anterior Olfactory Nucleus (Aon) Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

The Anterior Olfactory Nucleus (AON) is a critical structure in the olfactory system that serves as the primary relay and processing center for olfactory information traveling from the olfactory bulb to higher cortical areas. Located in the rostral part of the olfactory cortex, the AON plays essential roles in odor discrimination, olfactory memory, and the initial stages of olfactory perception.

Overview

flowchart TD
    cell_types_anterior_olfactory_["Anterior Olfactory Nucleus AON Neurons"]
    cell_types_anterior_olfactory_["infobox-cell"]
    cell_types_anterior_olfactory_ -->|"related to"| cell_types_anterior_olfactory_
    style cell_types_anterior_olfactory_ fill:#81c784,stroke:#333,color:#000
    cell_types_anterior_olfactory_["infobox-header"]
    cell_types_anterior_olfactory_ -->|"related to"| cell_types_anterior_olfactory_
    style cell_types_anterior_olfactory_ fill:#81c784,stroke:#333,color:#000
    cell_types_anterior_olfactory_["label"]
    cell_types_anterior_olfactory_ -->|"related to"| cell_types_anterior_olfactory_
    style cell_types_anterior_olfactory_ fill:#81c784,stroke:#333,color:#000
    cell_types_anterior_olfactory_["Taxonomy"]
    cell_types_anterior_olfactory_ -->|"related to"| cell_types_anterior_olfactory_
    style cell_types_anterior_olfactory_ fill:#81c784,stroke:#333,color:#000
    style cell_types_anterior_olfactory_ fill:#4fc3f7,stroke:#333,color:#000

The Anterior Olfactory Nucleus (AON) is a critical relay station in the olfactory system located in the rostral olfactory bulb and extending into the olfactory tract. As the first cortical region to receive processed olfactory information, the AON plays a fundamental role in odor discrimination, pattern separation, and olfactory memory consolidation. The AON receives input from the olfactory bulb’s mitral and tufted cells and projects to the piriform cortex, entorhinal cortex, and other olfactory cortical areas. In neurodegenerative diseases, the olfactory system is often affected early, with the AON showing pathological changes in both Alzheimer’s disease (where it exhibits early tau pathology and amyloid deposition) and Parkinson’s disease (where it is one of the earliest sites of alpha-synuclein Lewy pathology). The AON’s early involvement makes it a potential biomarker site for disease progression and a target for olfactory-based diagnostic approaches.

Multi-Taxonomy Classification

Taxonomy Database Cross-References

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• Cell Ontology (CL:0000207)

• OBO Foundry (CL:0000207)

• Allen Brain Cell Atlas

• CellxGene Census

• Human Cell Atlas

• PanglaoDB

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• Cell Ontology (CL:0000207)

• OBO Foundry (CL:0000207)

• Allen Brain Cell Atlas

• CellxGene Census

• PanglaoDB

Morphology and Markers

The AON contains both glutamatergic and GABAergic neuronal populations with distinct morphologies:

Morphological Characteristics

• Pyramidal neurons: Larger cell bodies (15-25 μm), apical dendrites extending toward the pial surface, basal dendrites with extensive branching

• Stellate interneurons: Smaller cell bodies (10-15 μm), radiate dendrites in all directions, local interneuron function

Normal Function

The Anterior Olfactory Nucleus serves several critical functions in the olfactory system:

Primary Functions

1. Odorant Processing: Receives direct input from mitral and tufted cells of the olfactory bulb, performing initial integration of odor information

2. Odor Discrimination: Helps distinguish between different odorants through pattern separation mechanisms

3. Olfactory Memory: Interfaces with the entorhinal cortex to form olfactory memories

4. Centrifugal Modulation: Receives feedback from cortical areas to modulate olfactory bulb activity

Circuitry

The AON forms a crucial node in the olfactory network:

• Input: Mitral and tufted cell axons from the olfactory bulb

• Processing: Local interneuron networks for gain control and pattern separation

• Output: Projects to piriform cortex, entorhinal cortex, and orbitofrontal cortex

• Modulation: Recieves cholinergic, noradrenergic, and serotonergic neuromodulation

Vulnerability in Disease

The Anterior Olfactory Nucleus shows remarkable vulnerability in several neurodegenerative diseases, often exhibiting early pathological changes:

Alzheimer’s Disease

• Tau pathology: Neurofibrillary tangles observed in AON neurons in early AD stages

• Amyloid deposition: β-Amyloid plaques can be found in AON

• Olfactory deficit: One of the earliest clinical signs of AD

• Functional imaging: Reduced metabolic activity in AON in MCI and early AD

• Mechanism: Early cholinergic denervation, β-amyloid deposition

Parkinson’s Disease

• α-Synuclein pathology: Lewy bodies in AON neurons in early stages (Braak stage 1-2)

• Olfactory dysfunction: Hyposmia/anosmia precedes motor symptoms by years

• Olfactory bulb pathology: Early Lewy body formation in olfactory bulb and AON

• Clinical correlation: Olfactory deficit correlates with non-motor symptoms

Other Neurodegenerative Conditions

• Dementia with Lewy Bodies: Extensive AON involvement

• Multiple System Atrophy: Olfactory function relatively preserved compared to PD

• Frontotemporal Dementia: Variable involvement of olfactory regions

• Huntington’s Disease: Olfactory deficits reported

Selective Vulnerability Factors

1. High metabolic demand: Active neuronal populations requiring substantial ATP

2. Direct environmental exposure: Olfactory epithelium directly exposed to toxins

3. Limited regenerative capacity: Adult neurogenesis declines with age

4. Protein aggregation susceptibility: Early accumulation of pathological proteins

Transcriptomic Profile

Single-cell transcriptomic studies reveal distinct neuronal populations in the AON:

Key Differentially Expressed Genes

Cell-Type Specific Signatures

• Glutamatergic neurons: SLC17A6+, VWA5B1+, GRM7+

• GABAergic neurons: GAD1+, GAD2+, SST+, PVALB+

• Progenitor cells: SOX2+, PAX6+, NES+

Therapeutic Implications

Understanding AON vulnerability provides therapeutic opportunities ^{1Olfactory dysfunction in neurodegenerative diseases2017 · Handb Clin Neurol · PMID 28160824Open reference 2Olfactory loss as prodromal marker in PD2016 · Neurology · PMID 26935862Open reference}:

Diagnostic Biomarkers

• Olfactory testing: UPSIT (University of Pennsylvania Smell Identification Test)

• Olfactory event-related potentials: Objective measurement of olfactory processing

• CSF biomarkers: Correlation with pathological burden

Therapeutic Targets

• Neurotrophic factors: BDNF delivery to support cholinergic neurons

• Antioxidants: Protect against oxidative stress

• Anti-inflammatory agents: Reduce neuroinflammation

• Olfactory rehabilitation: Olfactory training for functional recovery

Research Directions

• Olfactory epithelium biopsy: Accessible neuronal tissue for diagnosis

• Nasal spray delivery: Direct CNS drug delivery via olfactory pathway

• Stem cell therapy: Replace degenerated AON neurons

• Gene therapy: Target pathological protein expression

Olfactory Dysfunction as Clinical Biomarker

Clinical Utility

Olfactory testing has emerged as a valuable tool for neurodegenerative disease diagnosis ^{3Olfaction in neurodegenerative disease1998 · Ann Neurol · PMID 9664230Open reference 4Parkinson's disease and olfactory function1997 · Lancet · PMID 9118166Open reference}:

1. Early detection:

   • Olfactory deficits precede motor symptoms by years in PD

   • Memory complaints and olfactory loss correlate in pre-dementia AD

2. Differential diagnosis:

   • PD vs. atypical parkinsonian syndromes

   • AD vs. Lewy body dementia

   • Disease severity correlates with olfactory score

3. Progression monitoring:

   • Longitudinal olfactory testing tracks disease progression

   • Predictive of cognitive decline in MCI

Biomarker Development

• Olfactory epithelial biopsy: Accessible α-synuclein detection

• Nasal secretions: Proteomic biomarkers

• Olfactory bulb MRI: Volumetric changes

Circuitry and Connectivity

The AON forms a crucial node in the olfactory network ^{5Olfactory bulb and anterior olfactory nucleus2002 · Chem Senses · PMID 11838058Open reference}:

Input Pathways

Output Pathways

Neuromodulation

• Cholinergic: From basal forebrain, memory modulation

• Noradrenergic: From locus coeruleus, attention

• Serotonergic: From raphe, mood effects

Molecular Mechanisms of Vulnerability

Genetic Factors

• APP/PS1 models: Early olfactory deficits

• SNCA models: α-synuclein propagation via olfactory system

• Tau models: Olfactory bulb tau pathology

Protein Aggregation

1. α-Synuclein propagation:

   • Olfactory system as entry point

   • Prion-like spreading to CNS

   • Early Braak staging in olfactory regions

2. Amyloid deposition:

   • Aβ in olfactory bulb and AON

   • Correlates with olfactory dysfunction

   • Vascular amyloid co-localization

3. Tau pathology:

   • Neurofibrillary tangles in early AD

   • Entorhinal cortex gateway

   • Olfactory naming deficits

Neuroinflammation

• Microglial activation in olfactory regions

• Cytokine elevation in olfactory bulb

• Correlation with protein pathology

Cross-Linking

• Olfactory Bulb Mitral Cells — Primary olfactory neurons

• Olfactory Ensheathing Cells — Glial cells

• Entorhinal Cortex — Memory and AD

• Parkinson’s Disease — PD overview

• Alzheimer’s Disease — AD overview

• Lewy Body Dementia — LBD overview

• Mild Cognitive Impairment — Early AD

References

1. Walker DG et al., Olfactory neuron injury in AD (2020)

2. Dray N et al., Chaotic neuronal dynamics in olfactory nerve (2019)

3. Zhang Y et al., Olfactory dysfunction in neurodegenerative diseases (2018)

4. Attems J et al., Olfactory bulb involvement in AD (2015)

5. Braak H et al., Olfactory system in Lewy body disease (2012)

6. Bratton B et al., Anterior olfactory nucleus: structure and function (2010)

7. Kawasaki A et al., Olfactory dysfunction in neurodegenerative diseases (2021)

8. Morris JB et al., Anterior olfactory nucleus and olfactory processing (2019)

9. Doty RL et al., Olfactory dysfunction in neurodegenerative diseases (2017)

10. Mesholam RI et al., Olfaction in neurodegenerative disease (1998)

11. Hawkes CH et al., Parkinson’s disease and olfactory function (1997)

12. Kovács T et al., Alpha-synuclein in the human olfactory system (2004)

13. Seaberg JM et al., Olfactory bulb and anterior olfactory nucleus (2002)

14. Wilson RS et al., Olfactory impairment in MCI and AD (2011)

15. Postuma RB et al., Olfactory loss as prodromal marker in PD (2016)

Key Publications

[^1] Thomassen, J., & Bouthour, W. (2021). Olfactory dysfunction in neurodegenerative diseases: A window into the brain. Journal of Neurology, 268(10), 3557-3572.

[^2] Attems, J., et al. (2014). Olfactory pathology in neurodegenerative diseases. Cell and Tissue Research, 358(1), 1-15.

[^3] Wilson, R.S., et al. (2011). Olfactory impairment in mild cognitive impairment and Alzheimer’s disease. Journal of the American Geriatrics Society, 59(8), 1383-1390.

[^4] Doty, R.L. (2017). Olfactory dysfunction in neurodegenerative diseases. Handbook of Clinical Neurology, 164, 3-18.

[^5] Mesholam, R.I., et al. (1998). Olfaction in neurodegenerative disease: A meta-analysis. Annals of Neurology, 44(1), 43-51.

[^6] Braak, H., et al. (2003). Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease. Neurobiology of Aging, 24(2), 197-211.

[^7] Kovács, T., et al. (2001). Alpha-synuclein in the human olfactory system. Journal of Comparative Neurology, 441(1), 58-67.

[^8] Beach, T.G., et al. (2009). Olfactory bulb alpha-synucleinopathy in Alzheimer’s disease, Lewy body disease, and Parkinson’s disease. Brain Research, 1295, 183-191.

Background

The study of Anterior Olfactory Nucleus (Aon) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.